🇺🇸 FDA
Patent

US 11054423

Antibody-mediated neutralization of ebolaviruses

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 11054423 (Antibody-mediated neutralization of ebolaviruses) held by The Board of Regents of the University of Texas System expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/505, A61K2039/507, A61K2039/545, A61K39/395